Sublingual epinephrine tablets

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12042472
SERIAL NO

17575489

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides sublingual epinephrine tablets and methods of treating anaphylaxis, methods for concomitant therapy during a cardiac event, treating hypoglycemia, and prophylaxis for immunotherapy, using sublingual epinephrine tablets.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PHASE PHARMACEUTICALS LLC14911 LAKE FOREST DR DALLAS TX 75254

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Farina, Nicholas J Dallas, US 4 0
Howard, Christopher Dallas, US 37 112
Howard, G Lynn Dallas, US 4 0
Walters, Edward J Dallas, US 14 315

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jan 23, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 23, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 23, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00